GlassScriptPhysician profile
Bhavin B Mehta
NPI 1881835973
$858.92
in general payments reported to CMS, 2019-2025
16 companies · $305 in 2025
The $305 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2020: $41.27 · 2021: $13.71 · 2022: $17.01 · 2023: $52.47 · 2024: $232 · 2025: $305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $590.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $589.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $181.90 | 2019-2024 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $148.11 | 2020-2025 | Airsupra, Breztri, Tezspire |
| Janssen Pharmaceuticals, INC | $140.65 | 2019 | |
| Abiomed | $129.99 | 2025 | |
| Boston Scientific Corporation | $38.88 | 2025 | General - Vascular Intervention |
| Insmed, INC. | $31.75 | 2025 | Arikayce |
| Vapotherm INC | $29.10 | 2020 | |
| Glaxosmithkline, LLC. | $25.28 | 2019-2021 | |
| Grifols USA, LLC | $19.68 | 2024 | Prolastin-C Liquid |
| Mylan Specialty L.P. | $18.40 | 2023 | Yupelri |
| 3b Medical, INC. | $17.90 | 2025 | Luna |
| Jazz Pharmaceuticals INC. | $17.59 | 2019 | |
| Novartis Pharmaceuticals Corporation | $17.01 | 2022 | |
| Merck Sharp & Dohme LLC | $16.75 | 2023 | Belsomra |
| Pulmonx Corporation | $14.88 | 2024 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Breas Medical, INC. | $11.05 | 2025 | Vivo 45 Ls |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bhavin Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.